Replimune (REPL) Price to FCF (2018 - 2026)
Powered by 
Analysis
Replimune (REPL) Price to FCF (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.55 Bn | 58.37 Bn | 1.37 Bn |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 6 | BeOne Medicines | 39.98 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.32 Bn | 32.01 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.59 Bn | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn |
| 10 | Replimune | 1.45 Bn | 1.45 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -12.28 |
| Mar 31, 2026 | -11.27 |
| Dec 31, 2025 | -11.71 |
| Sep 30, 2025 | -3.98 |
| Jun 30, 2025 | -9.06 |
| Mar 31, 2025 | -13.70 |
| Dec 31, 2024 | -17.76 |
| Sep 30, 2024 | -18.41 |
| Jun 30, 2024 | -12.09 |
| Mar 31, 2024 | -10.47 |
| Dec 31, 2023 | -10.60 |
| Sep 30, 2023 | -22.29 |
| Jun 30, 2023 | -27.93 |
| Mar 31, 2023 | -30.29 |
| Dec 31, 2022 | -52.86 |
| Sep 30, 2022 | -25.56 |
| Jun 30, 2022 | -24.96 |
| Mar 31, 2022 | -33.90 |
| Dec 31, 2021 | -68.00 |
| Sep 30, 2021 | -59.38 |